Home | By sponsor

NATIONAL CENTER OF BIOPRODUCTS

Trials shown by sponsor

Public titlesort icon Date of Registration State
Biomodulin T in older adult for protection in events of local transmission of COVID-19 10/09/2020 Registered
Biomodulin T Intramuscular for Thymus Hypoplasia in Children. Phase III 14/08/2017 Registered outdated
Biomodulin T-IM-oncological adults post chemotherapy-prevention COVID-19. Exploratory study 21/12/2020 Registered
Biomodulina T - IM - covid-19 - older adult 29/05/2020 Registered
Biomodulina T - IM- covid-19 - older adultos - Phase IV clinical trial 05/05/2020 Registered
BIOMODULINA T in a long-lived population at high risk of COVID-19 infection 19/09/2020 Registered
Biomodulina T in pediatric septic shock. Exploratory study 03/08/2020 Registered
Combifer vs NeotrofinCF-Anemia-Pregnant-Phase II 13/04/2015 Registered
Combifer vs Trofin phase II in anemic pregnant women. 08/04/2015 Registered
Combifer-T, Trofin and Ferrous Fumarate in iron-deficiency anemia in pregnant women. 14/01/2019 Registered
Combined Subcutaneous immunotherapy VALERGEN-DP and VALERGEN-BT-Asthma-Adults-Phase II 2012-04-13 Registered
Combined sublingual immunotherapy VALERGEN-DP and VALERGEN-BT-Asthma-Adults-Phase II 17/02/2017 Registered
Efficacy of nasal provocation test with VALERGEN-DP, DS and BT 15/04/2019 Registered outdated
Efficacy of VALERGEN-BT sublingual vaccine in asthmatic adults. 2010-12-08 Registered
Efficacy of VALERGEN-DP subcutaneous vaccine in asthmatic adults 2010-12-07 Registered
Efficacy of VALERGEN-DP sublingual vaccine in asthmatic adults. 2010-12-09 Registered
Efficacy of VALERGEN-DS subcutaneous vaccine in asthmatic adults. 2010-12-07 Registered
Efficacy of VALERGEN-DS sublingual vaccine in asthmatic adults 2010-12-08 Registered
Efficacy of VALERGENT-BT subcutaneous vaccine in asthmatic adults 2010-12-07 Registered
Evaluation of Biomodulin T sublingual Vs intramuscular in the elderly. 13/04/2015 Registered